+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Sale

Cardiac Safety Services Market by Service Type (Blood Pressure Measurement Services, Cardiovascular Imaging Services, ECG or Holter Measurement Services), Type (Integrated Services, Standalone Services), Application, End User - Global Forecast 2025-2030

  • PDF Icon

    Report

  • 198 Pages
  • March 2025
  • Region: Global
  • 360iResearch™
  • ID: 4995402
UP TO OFF until Jan 01st 2026
1h Free Analyst Time
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The Cardiac Safety Services Market grew from USD 1.22 billion in 2023 to USD 1.33 billion in 2024. It is expected to continue growing at a CAGR of 9.71%, reaching USD 2.34 billion by 2030.

In the realm of cardiac safety services, the industry is undergoing a pivotal transformation driven by rapid technological advancements and evolving regulatory frameworks. Over recent years, the integration of sophisticated diagnostic and therapeutic solutions has redefined how cardiac safety is approached across the healthcare continuum. Stakeholders from medical research institutions to regulatory agencies and commercial enterprises are focusing on ensuring that cardiac evaluations are not only accurate but also aligned with the rigorous demands of modern drug and device development.

The market for cardiac safety services has witnessed an expansion in scope, moving beyond traditional measurement and analysis to incorporate digital health tools and real-time monitoring systems. This evolution has been influenced by the growing prevalence of cardiovascular diseases, the need for early detection of cardiac risks, and the increasing complexity of therapies requiring comprehensive safety assessments. As clinical trials and real-world evidence scenarios become more demanding, the ecosystem is adapting to deliver precise, efficient, and scalable service models.

With an increase in research investments and the adoption of innovative technologies, the sector is now more resilient and responsive than ever before. This introductory examination sets the stage for a deep dive into the emerging trends, sophisticated segmentation rationales, regional market dynamics, and the competitive landscape that together are reshaping cardiac safety services. The ensuing analysis provides a strategic overview, illustrating how integrated diagnostic methods and continuous data analytics are establishing new benchmarks in clinical safety evaluations.

Transformative Shifts in the Cardiac Safety Landscape

The cardiac safety landscape is in the midst of a transformative evolution, driven by technological innovation and shifting healthcare paradigms. Recent advancements in digital diagnostics, imaging technologies, and biomarker analytics have bolstered the accuracy and timeliness of cardiac evaluations. These innovations have led to a harmonization of clinical trials and post-market surveillance, ensuring that safety assessments are more dynamic and responsive to patient needs.

Emerging technologies now allow for more precise measurements, enabling healthcare providers to capture minute changes in cardiac function. The paradigm shift is clear: from static and periodic assessments to continuous, real-time monitoring systems that seamlessly integrate with patient care. This transition is powered by the convergence of electronic health records, wearable devices, and advanced imaging techniques, which collectively contribute to a more comprehensive understanding of cardiac health. Clinicians and researchers are now equipped with the tools to quickly identify potential risks, refine treatment protocols, and improve overall patient outcomes.

Furthermore, regulatory agencies are adapting to these changes by updating guidelines and compliance frameworks to support innovative approaches. This creates a dynamic interplay between innovation and oversight where both industry leaders and regulatory bodies work in tandem to drive improvements. As cardiac safety services evolve, the market is clearly witnessing a shift towards solutions that are not only more accurate but also more adaptable to the rapidly changing healthcare environment.

Key Segmentation Insights in Cardiac Safety

A critical aspect of understanding the cardiac safety services market lies in its detailed segmentation, which offers vital insights into the multifaceted nature of the industry. The first level of segmentation categorizes services based on service type, where the market is thoroughly studied across various offerings including blood pressure measurement services, cardiovascular imaging services, ECG or Holter measurement services, and thorough QT studies. Each of these service types caters to distinct aspects of cardiac safety, providing comprehensive diagnostic and monitoring capabilities.

Beyond service type, the market segmentation extends to how services are rendered. The analysis distinguishes between integrated services, which combine multiple diagnostic facets under a unified umbrella, and standalone services that deliver focused, specialized results. This segmentation highlights the growing preference for holistic approaches in clinical evaluations, as well as the niche demand for specialized services that address specific cardiac concerns.

Furthermore, the market is segmented based on application, focusing on drug and device development and the stringent requirements of regulatory compliance. This differentiation not only underscores the importance of safety assessments in the innovation cycle but also emphasizes the rigorous standards that new therapies and devices must meet before reaching the market. Evaluating performance through these two distinct lenses allows stakeholders to appreciate the dual role that cardiac safety services play in both pioneering new treatments and in maintaining the safety of existing therapeutic modalities.

Finally, segmentation based on end users provides insights into the diverse clientele that benefits from these services. The market spans contract research organizations, pharmaceutical and biopharma companies, and research institutes. Each of these segments leverages cardiac safety evaluations to enhance clinical trial efficiency, ensure compliance with regulatory standards, and drive the innovation necessary for advanced drug and device development. These layered insights into service, type, application, and end-user deliver a holistic view of the market, illuminating the strategic direction and investment opportunities available within cardiac safety services.

Based on Service Type, market is studied across Blood Pressure Measurement Services, Cardiovascular Imaging Services, ECG or Holter Measurement Services, and Thorough QT Studies.

Based on Type, market is studied across Integrated Services and Standalone Services.

Based on Application, market is studied across Drug & Device Development and Regulatory Compliance Requirements.

Based on End User, market is studied across Contract Research Organizations, Pharmaceutical & Biopharma, and Research Institutes.

Regional Perspectives on Cardiac Safety Developments

Regional insights into the cardiac safety landscape reveal a nuanced picture of market dynamics that vary across global territories. In the Americas, rapid advancements in healthcare infrastructure and a sustained commitment to clinical excellence have positioned the region as a hotbed for innovative cardiac safety solutions. North American markets, in particular, benefit from high regulatory standards and significant investment in medical research, making them attractive hubs for emerging diagnostic technologies.

The landscape in Europe, the Middle East, and Africa is characterized by a blend of traditional healthcare excellence and a growing embrace of digital health innovations. European centers continue to uphold stringent safety measures and regulatory compliance, while countries in the Middle East and Africa are progressively incorporating advanced monitoring systems. This mix of robust legacy systems and novel approaches enhances the overall capacity for delivering sophisticated cardiac safety services.

In the Asia-Pacific region, a rapidly evolving healthcare system, propelled by significant economic growth and a burgeoning focus on technology-driven healthcare solutions, offers ample opportunities for market expansion. The region's diverse economies are investing heavily in infrastructure and R&D initiatives, which are essential for supporting advanced diagnostic and therapeutic modalities in cardiac care. These regional insights not only highlight the varying stages of market maturity but also illustrate where strategic investments and collaborative research initiatives are most likely to yield substantial returns.

Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, Massachusetts, New York, North Carolina, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

Leading Players in the Cardiac Safety Services Market

An examination of key players in the cardiac safety services market underscores a highly competitive and innovative landscape driven by several prominent companies. Industry leaders such as ACM Global Laboratories have long been recognized for their robust testing protocols and commitment to advancing diagnostic services. Companies like Advarra, Inc., and Banook Group continue to set high benchmarks in quality, ensuring that clinical evaluations are conducted with precision and care. This competitive spirit is further fueled by the contributions of firms such as Biotrial and Celerion, whose expertise in integrating sophisticated diagnostics with clinical trial management has reshaped market expectations.

Certara, Inc. and Charles River Laboratories International, Inc. bring extensive experience in regulatory compliance and clinical services, providing invaluable insights into both integrated and standalone diagnostic methods. Inspire of being at the forefront of technological integration, Circle Cardiovascular Imaging Inc. and Clario have successfully implemented advanced imaging techniques that offer enhanced accuracy in cardiovascular assessments. Companies like Clyde Biosciences Limited and Eurofins Scientific SE continue to innovate across multiple service types, including emerging modalities that further the understanding of cardiac health metrics.

The market is also bolstered by well-established names such as GE HealthCare Technologies Inc. and ICON PLC, whose comprehensive portfolios span a range of diagnostic and monitoring solutions. This is complemented by the analytical prowess of IQVIA Holdings Inc. and Koninklijke Philips N.V., which have continuously driven market trends through research-driven insights and product development. The broad spectrum of expertise is enhanced by Laboratory Corporation of America Holdings, Medpace, Inc., and MERIT CRO, Inc., all of which contribute to a diverse competitive landscape. As we consider the strategic implications of market leadership, it is important to note the role played by Metrion Biosciences Limited, Ncardia Services B.V., and NEXEL Co., Ltd., among others, whose innovations in cardiac diagnostics further underscore the sector’s commitment to safety and efficacy. Meanwhile, Octagos Health, Inc., Parexel International Corporation, PhysioStim SAS, PPD, Inc. by Thermo Fisher Scientific Inc., Richmond Pharmacology Limited, Shanghai Medicilon Inc., and Worldwide Clinical Trials illustrate the global reach and multidimensional expertise of the market. Collectively, these companies represent a dynamic interplay of technology, clinical expertise, and regulatory adherence, fostering a competitive ecosystem that drives continuous improvement in cardiac safety services.

The report delves into recent significant developments in the Cardiac Safety Services Market, highlighting leading vendors and their innovative profiles. These include ACM Global Laboratories, Advarra, Inc., Banook Group, Biotrial, Celerion, Certara, Inc., Charles River Laboratories International, Inc., Circle Cardiovascular Imaging Inc., Clario, Clyde Biosciences Limited, Eurofins Scientific SE, GE HealthCare Technologies Inc., ICON PLC, IQVIA Holdings Inc., Koninklijke Philips N.V., Laboratory Corporation of America Holdings, Medpace, Inc., MERIT CRO, Inc., Metrion Biosciences Limited, Ncardia Services B.V., NEXEL Co., Ltd., Octagos Health, Inc., Parexel International Corporation, PhysioStim SAS, PPD, Inc. by Thermo Fisher Scientific Inc., Richmond Pharmacology Limited, Shanghai Medicilon Inc., and Worldwide Clinical Trials.

Actionable Recommendations for Industry Leaders

For industry leaders looking to navigate this complex and rapidly evolving market, several actionable recommendations are crucial. Firstly, embracing technological integration is key. Companies should invest in the latest digital diagnostic tools and data analytics platforms that enhance real-time monitoring and predictive analysis capabilities. This will not only streamline clinical processes, but also facilitate accurate safety profiling of therapies and devices.

Secondly, fostering collaborations, both internally and across industry boundaries, can drive innovation and operational efficiency. By partnering with research institutes and technology providers, organizations can gain access to cutting-edge insights and synergistic solutions that address the multifaceted challenges of cardiac safety. Additionally, a commitment to continuous improvement and iterative learning will ensure that strategies remain agile and responsive to regulatory and market shifts.

Thirdly, maintaining stringent adherence to compliance standards and proactively engaging with regulatory bodies will build trust and enhance market credibility. As the regulatory landscape becomes increasingly complex, organizations must undertake robust training and development programs for their teams to ensure a deep understanding of evolving guidelines. Finally, leaders should explore avenues to diversify service offerings. By expanding both integrated and standalone services, companies can meet diverse client needs across drug development, device safety assessments, and compliance requirements. This multi-pronged approach will position industry players not just as service providers, but also as strategic partners in the broader healthcare ecosystem.

In conclusion, the cardiac safety services market is at an inflection point where technological advancements, regulatory shifts, and strategic segmentation come together to redefine industry standards. The insights presented in this report illustrate a dynamic market that is rapidly evolving, fueled by innovations in diagnostic technology and a commitment to clinical excellence. As stakeholders continue to prioritize patient safety and regulatory compliance, the opportunities for growth and innovation are manifold.

The integration of advanced imaging solutions, real-time monitoring systems, and comprehensive diagnostic services has paved the way for a more resilient and responsive cardiac safety framework. Whether viewed through the lens of detailed segmentation or regional market dynamics, it is evident that the future belongs to those who can seamlessly bridge the gap between innovation and operational execution. This conclusion not only underscores the current state of the market but also offers a forward-looking perspective that encourages stakeholders to anticipate and adapt to emerging trends.

With the purchase of this report at the Multi-user License or greater level, you will have access to one hour with an expert analyst who will help you link key findings in the report to the business issues you're addressing. This will need to be used within three months of purchase.

This report also includes a complimentary Excel file with data from the report for purchasers at the Site License or greater level.

Please note:

  • Online Access price format is valid for 60 days access. Printing is not enabled.
  • PDF Single and Enterprise price formats enable printing.

 

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Increased incidence of heart-related ailments & rising need for novel drug development globally
5.1.1.2. Rising CRO outsourcing services by pharmaceutical firms
5.1.2. Restraints
5.1.2.1. Concern associated with integration of cardiac safety technologies with existing healthcare IT infrastructures
5.1.3. Opportunities
5.1.3.1. Ongoing integration of artificial intelligence and machine learning improving the accuracy of cardiac monitoring
5.1.3.2. Increasing public- private investment in novel clinical research
5.1.4. Challenges
5.1.4.1. Regulatory compliance and incentives associated with cardiac safety services
5.2. Market Segmentation Analysis
5.2.1. Service Type: Rising need of holter measurement services for monitoring the drug's effect on cardiac rhythm
5.2.2. Type: Utilization of standalone services due to flexibility and precision in targeting precise cardiac parameters
5.2.3. Application: Preference for drug & device development enhances the detection of cardiac side effects
5.2.4. End User: Innovations in cardiac safety evolving role of contract research organizations in clinical trials
5.3. Porter’s Five Forces Analysis
5.3.1. Threat of New Entrants
5.3.2. Threat of Substitutes
5.3.3. Bargaining Power of Customers
5.3.4. Bargaining Power of Suppliers
5.3.5. Industry Rivalry
5.4. PESTLE Analysis
5.4.1. Political
5.4.2. Economic
5.4.3. Social
5.4.4. Technological
5.4.5. Legal
5.4.6. Environmental
6. Cardiac Safety Services Market, by Service Type
6.1. Introduction
6.2. Blood Pressure Measurement Services
6.3. Cardiovascular Imaging Services
6.4. ECG or Holter Measurement Services
6.5. Thorough QT Studies
7. Cardiac Safety Services Market, by Type
7.1. Introduction
7.2. Integrated Services
7.3. Standalone Services
8. Cardiac Safety Services Market, by Application
8.1. Introduction
8.2. Drug & Device Development
8.3. Regulatory Compliance Requirements
9. Cardiac Safety Services Market, by End User
9.1. Introduction
9.2. Contract Research Organizations
9.3. Pharmaceutical & Biopharma
9.4. Research Institutes
10. Americas Cardiac Safety Services Market
10.1. Introduction
10.2. Argentina
10.3. Brazil
10.4. Canada
10.5. Mexico
10.6. United States
11. Asia-Pacific Cardiac Safety Services Market
11.1. Introduction
11.2. Australia
11.3. China
11.4. India
11.5. Indonesia
11.6. Japan
11.7. Malaysia
11.8. Philippines
11.9. Singapore
11.10. South Korea
11.11. Taiwan
11.12. Thailand
11.13. Vietnam
12. Europe, Middle East & Africa Cardiac Safety Services Market
12.1. Introduction
12.2. Denmark
12.3. Egypt
12.4. Finland
12.5. France
12.6. Germany
12.7. Israel
12.8. Italy
12.9. Netherlands
12.10. Nigeria
12.11. Norway
12.12. Poland
12.13. Qatar
12.14. Russia
12.15. Saudi Arabia
12.16. South Africa
12.17. Spain
12.18. Sweden
12.19. Switzerland
12.20. Turkey
12.21. United Arab Emirates
12.22. United Kingdom
13. Competitive Landscape
13.1. Market Share Analysis, 2023
13.2. FPNV Positioning Matrix, 2023
13.3. Competitive Scenario Analysis
13.3.1. Medera's Novoheart and Curi Bio collaborate for advancements in cardiac drug screening
13.3.2. Lindus Health launches All-in-One cardiovascular CRO for streamlined clinical trials
13.3.3. Medicalgorithmics expands into clinical trials with AI-driven cardiac safety services
13.3.4. CSRC think tank program advancing cardiac safety through remote monitoring and AI integration
13.3.5. Clario and AliveCor partnered to enhance cardiac safety monitoring in decentralized clinical trials
13.4. Strategy Analysis & Recommendation
13.4.1. Banook Group
13.4.2. Clario
13.4.3. ICON PLC
13.4.4. IQVIA Holdings Inc.
List of Figures
FIGURE 1. CARDIAC SAFETY SERVICES MARKET MULTI-CURRENCY
FIGURE 2. CARDIAC SAFETY SERVICES MARKET MULTI-LANGUAGE
FIGURE 3. CARDIAC SAFETY SERVICES MARKET RESEARCH PROCESS
FIGURE 4. CARDIAC SAFETY SERVICES MARKET SIZE, 2023 VS 2030
FIGURE 5. GLOBAL CARDIAC SAFETY SERVICES MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 6. GLOBAL CARDIAC SAFETY SERVICES MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL CARDIAC SAFETY SERVICES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 8. GLOBAL CARDIAC SAFETY SERVICES MARKET SIZE, BY SERVICE TYPE, 2023 VS 2030 (%)
FIGURE 9. GLOBAL CARDIAC SAFETY SERVICES MARKET SIZE, BY SERVICE TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 10. GLOBAL CARDIAC SAFETY SERVICES MARKET SIZE, BY TYPE, 2023 VS 2030 (%)
FIGURE 11. GLOBAL CARDIAC SAFETY SERVICES MARKET SIZE, BY TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 12. GLOBAL CARDIAC SAFETY SERVICES MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
FIGURE 13. GLOBAL CARDIAC SAFETY SERVICES MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 14. GLOBAL CARDIAC SAFETY SERVICES MARKET SIZE, BY END USER, 2023 VS 2030 (%)
FIGURE 15. GLOBAL CARDIAC SAFETY SERVICES MARKET SIZE, BY END USER, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 16. AMERICAS CARDIAC SAFETY SERVICES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 17. AMERICAS CARDIAC SAFETY SERVICES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 18. UNITED STATES CARDIAC SAFETY SERVICES MARKET SIZE, BY STATE, 2023 VS 2030 (%)
FIGURE 19. UNITED STATES CARDIAC SAFETY SERVICES MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 20. ASIA-PACIFIC CARDIAC SAFETY SERVICES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 21. ASIA-PACIFIC CARDIAC SAFETY SERVICES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 22. EUROPE, MIDDLE EAST & AFRICA CARDIAC SAFETY SERVICES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 23. EUROPE, MIDDLE EAST & AFRICA CARDIAC SAFETY SERVICES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 24. CARDIAC SAFETY SERVICES MARKET SHARE, BY KEY PLAYER, 2023
FIGURE 25. CARDIAC SAFETY SERVICES MARKET, FPNV POSITIONING MATRIX, 2023
List of Tables
TABLE 1. CARDIAC SAFETY SERVICES MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
TABLE 3. GLOBAL CARDIAC SAFETY SERVICES MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL CARDIAC SAFETY SERVICES MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. GLOBAL CARDIAC SAFETY SERVICES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 6. CARDIAC SAFETY SERVICES MARKET DYNAMICS
TABLE 7. GLOBAL CARDIAC SAFETY SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
TABLE 8. GLOBAL CARDIAC SAFETY SERVICES MARKET SIZE, BY BLOOD PRESSURE MEASUREMENT SERVICES, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. GLOBAL CARDIAC SAFETY SERVICES MARKET SIZE, BY CARDIOVASCULAR IMAGING SERVICES, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. GLOBAL CARDIAC SAFETY SERVICES MARKET SIZE, BY ECG OR HOLTER MEASUREMENT SERVICES, BY REGION, 2018-2030 (USD MILLION)
TABLE 11. GLOBAL CARDIAC SAFETY SERVICES MARKET SIZE, BY THOROUGH QT STUDIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 12. GLOBAL CARDIAC SAFETY SERVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 13. GLOBAL CARDIAC SAFETY SERVICES MARKET SIZE, BY INTEGRATED SERVICES, BY REGION, 2018-2030 (USD MILLION)
TABLE 14. GLOBAL CARDIAC SAFETY SERVICES MARKET SIZE, BY STANDALONE SERVICES, BY REGION, 2018-2030 (USD MILLION)
TABLE 15. GLOBAL CARDIAC SAFETY SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 16. GLOBAL CARDIAC SAFETY SERVICES MARKET SIZE, BY DRUG & DEVICE DEVELOPMENT, BY REGION, 2018-2030 (USD MILLION)
TABLE 17. GLOBAL CARDIAC SAFETY SERVICES MARKET SIZE, BY REGULATORY COMPLIANCE REQUIREMENTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 18. GLOBAL CARDIAC SAFETY SERVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 19. GLOBAL CARDIAC SAFETY SERVICES MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, BY REGION, 2018-2030 (USD MILLION)
TABLE 20. GLOBAL CARDIAC SAFETY SERVICES MARKET SIZE, BY PHARMACEUTICAL & BIOPHARMA, BY REGION, 2018-2030 (USD MILLION)
TABLE 21. GLOBAL CARDIAC SAFETY SERVICES MARKET SIZE, BY RESEARCH INSTITUTES, BY REGION, 2018-2030 (USD MILLION)
TABLE 22. AMERICAS CARDIAC SAFETY SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
TABLE 23. AMERICAS CARDIAC SAFETY SERVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 24. AMERICAS CARDIAC SAFETY SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 25. AMERICAS CARDIAC SAFETY SERVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 26. AMERICAS CARDIAC SAFETY SERVICES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 27. ARGENTINA CARDIAC SAFETY SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
TABLE 28. ARGENTINA CARDIAC SAFETY SERVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 29. ARGENTINA CARDIAC SAFETY SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 30. ARGENTINA CARDIAC SAFETY SERVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 31. BRAZIL CARDIAC SAFETY SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
TABLE 32. BRAZIL CARDIAC SAFETY SERVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 33. BRAZIL CARDIAC SAFETY SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 34. BRAZIL CARDIAC SAFETY SERVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 35. CANADA CARDIAC SAFETY SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
TABLE 36. CANADA CARDIAC SAFETY SERVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 37. CANADA CARDIAC SAFETY SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 38. CANADA CARDIAC SAFETY SERVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 39. MEXICO CARDIAC SAFETY SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
TABLE 40. MEXICO CARDIAC SAFETY SERVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 41. MEXICO CARDIAC SAFETY SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 42. MEXICO CARDIAC SAFETY SERVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 43. UNITED STATES CARDIAC SAFETY SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
TABLE 44. UNITED STATES CARDIAC SAFETY SERVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 45. UNITED STATES CARDIAC SAFETY SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 46. UNITED STATES CARDIAC SAFETY SERVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 47. UNITED STATES CARDIAC SAFETY SERVICES MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 48. ASIA-PACIFIC CARDIAC SAFETY SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
TABLE 49. ASIA-PACIFIC CARDIAC SAFETY SERVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 50. ASIA-PACIFIC CARDIAC SAFETY SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 51. ASIA-PACIFIC CARDIAC SAFETY SERVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 52. ASIA-PACIFIC CARDIAC SAFETY SERVICES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 53. AUSTRALIA CARDIAC SAFETY SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
TABLE 54. AUSTRALIA CARDIAC SAFETY SERVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 55. AUSTRALIA CARDIAC SAFETY SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 56. AUSTRALIA CARDIAC SAFETY SERVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 57. CHINA CARDIAC SAFETY SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
TABLE 58. CHINA CARDIAC SAFETY SERVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 59. CHINA CARDIAC SAFETY SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 60. CHINA CARDIAC SAFETY SERVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 61. INDIA CARDIAC SAFETY SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
TABLE 62. INDIA CARDIAC SAFETY SERVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 63. INDIA CARDIAC SAFETY SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 64. INDIA CARDIAC SAFETY SERVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 65. INDONESIA CARDIAC SAFETY SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
TABLE 66. INDONESIA CARDIAC SAFETY SERVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 67. INDONESIA CARDIAC SAFETY SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 68. INDONESIA CARDIAC SAFETY SERVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 69. JAPAN CARDIAC SAFETY SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
TABLE 70. JAPAN CARDIAC SAFETY SERVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 71. JAPAN CARDIAC SAFETY SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 72. JAPAN CARDIAC SAFETY SERVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 73. MALAYSIA CARDIAC SAFETY SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
TABLE 74. MALAYSIA CARDIAC SAFETY SERVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 75. MALAYSIA CARDIAC SAFETY SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 76. MALAYSIA CARDIAC SAFETY SERVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 77. PHILIPPINES CARDIAC SAFETY SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
TABLE 78. PHILIPPINES CARDIAC SAFETY SERVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 79. PHILIPPINES CARDIAC SAFETY SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 80. PHILIPPINES CARDIAC SAFETY SERVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 81. SINGAPORE CARDIAC SAFETY SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
TABLE 82. SINGAPORE CARDIAC SAFETY SERVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 83. SINGAPORE CARDIAC SAFETY SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 84. SINGAPORE CARDIAC SAFETY SERVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 85. SOUTH KOREA CARDIAC SAFETY SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
TABLE 86. SOUTH KOREA CARDIAC SAFETY SERVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 87. SOUTH KOREA CARDIAC SAFETY SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 88. SOUTH KOREA CARDIAC SAFETY SERVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 89. TAIWAN CARDIAC SAFETY SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
TABLE 90. TAIWAN CARDIAC SAFETY SERVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 91. TAIWAN CARDIAC SAFETY SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 92. TAIWAN CARDIAC SAFETY SERVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 93. THAILAND CARDIAC SAFETY SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
TABLE 94. THAILAND CARDIAC SAFETY SERVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 95. THAILAND CARDIAC SAFETY SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 96. THAILAND CARDIAC SAFETY SERVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 97. VIETNAM CARDIAC SAFETY SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
TABLE 98. VIETNAM CARDIAC SAFETY SERVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 99. VIETNAM CARDIAC SAFETY SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 100. VIETNAM CARDIAC SAFETY SERVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 101. EUROPE, MIDDLE EAST & AFRICA CARDIAC SAFETY SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
TABLE 102. EUROPE, MIDDLE EAST & AFRICA CARDIAC SAFETY SERVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 103. EUROPE, MIDDLE EAST & AFRICA CARDIAC SAFETY SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 104. EUROPE, MIDDLE EAST & AFRICA CARDIAC SAFETY SERVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 105. EUROPE, MIDDLE EAST & AFRICA CARDIAC SAFETY SERVICES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 106. DENMARK CARDIAC SAFETY SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
TABLE 107. DENMARK CARDIAC SAFETY SERVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 108. DENMARK CARDIAC SAFETY SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 109. DENMARK CARDIAC SAFETY SERVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 110. EGYPT CARDIAC SAFETY SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
TABLE 111. EGYPT CARDIAC SAFETY SERVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 112. EGYPT CARDIAC SAFETY SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 113. EGYPT CARDIAC SAFETY SERVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 114. FINLAND CARDIAC SAFETY SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
TABLE 115. FINLAND CARDIAC SAFETY SERVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 116. FINLAND CARDIAC SAFETY SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 117. FINLAND CARDIAC SAFETY SERVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 118. FRANCE CARDIAC SAFETY SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
TABLE 119. FRANCE CARDIAC SAFETY SERVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 120. FRANCE CARDIAC SAFETY SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 121. FRANCE CARDIAC SAFETY SERVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 122. GERMANY CARDIAC SAFETY SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
TABLE 123. GERMANY CARDIAC SAFETY SERVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 124. GERMANY CARDIAC SAFETY SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 125. GERMANY CARDIAC SAFETY SERVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 126. ISRAEL CARDIAC SAFETY SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
TABLE 127. ISRAEL CARDIAC SAFETY SERVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 128. ISRAEL CARDIAC SAFETY SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 129. ISRAEL CARDIAC SAFETY SERVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 130. ITALY CARDIAC SAFETY SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
TABLE 131. ITALY CARDIAC SAFETY SERVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 132. ITALY CARDIAC SAFETY SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 133. ITALY CARDIAC SAFETY SERVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 134. NETHERLANDS CARDIAC SAFETY SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
TABLE 135. NETHERLANDS CARDIAC SAFETY SERVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 136. NETHERLANDS CARDIAC SAFETY SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 137. NETHERLANDS CARDIAC SAFETY SERVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 138. NIGERIA CARDIAC SAFETY SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
TABLE 139. NIGERIA CARDIAC SAFETY SERVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 140. NIGERIA CARDIAC SAFETY SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 141. NIGERIA CARDIAC SAFETY SERVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 142. NORWAY CARDIAC SAFETY SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
TABLE 143. NORWAY CARDIAC SAFETY SERVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 144. NORWAY CARDIAC SAFETY SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 145. NORWAY CARDIAC SAFETY SERVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 146. POLAND CARDIAC SAFETY SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
TABLE 147. POLAND CARDIAC SAFETY SERVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 148. POLAND CARDIAC SAFETY SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 149. POLAND CARDIAC SAFETY SERVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 150. QATAR CARDIAC SAFETY SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
TABLE 151. QATAR CARDIAC SAFETY SERVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 152. QATAR CARDIAC SAFETY SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 153. QATAR CARDIAC SAFETY SERVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 154. RUSSIA CARDIAC SAFETY SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
TABLE 155. RUSSIA CARDIAC SAFETY SERVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 156. RUSSIA CARDIAC SAFETY SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 157. RUSSIA CARDIAC SAFETY SERVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 158. SAUDI ARABIA CARDIAC SAFETY SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
TABLE 159. SAUDI ARABIA CARDIAC SAFETY SERVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 160. SAUDI ARABIA CARDIAC SAFETY SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 161. SAUDI ARABIA CARDIAC SAFETY SERVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 162. SOUTH AFRICA CARDIAC SAFETY SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
TABLE 163. SOUTH AFRICA CARDIAC SAFETY SERVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 164. SOUTH AFRICA CARDIAC SAFETY SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 165. SOUTH AFRICA CARDIAC SAFETY SERVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 166. SPAIN CARDIAC SAFETY SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
TABLE 167. SPAIN CARDIAC SAFETY SERVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 168. SPAIN CARDIAC SAFETY SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 169. SPAIN CARDIAC SAFETY SERVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 170. SWEDEN CARDIAC SAFETY SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
TABLE 171. SWEDEN CARDIAC SAFETY SERVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 172. SWEDEN CARDIAC SAFETY SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 173. SWEDEN CARDIAC SAFETY SERVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 174. SWITZERLAND CARDIAC SAFETY SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
TABLE 175. SWITZERLAND CARDIAC SAFETY SERVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 176. SWITZERLAND CARDIAC SAFETY SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 177. SWITZERLAND CARDIAC SAFETY SERVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 178. TURKEY CARDIAC SAFETY SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
TABLE 179. TURKEY CARDIAC SAFETY SERVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 180. TURKEY CARDIAC SAFETY SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 181. TURKEY CARDIAC SAFETY SERVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 182. UNITED ARAB EMIRATES CARDIAC SAFETY SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
TABLE 183. UNITED ARAB EMIRATES CARDIAC SAFETY SERVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 184. UNITED ARAB EMIRATES CARDIAC SAFETY SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 185. UNITED ARAB EMIRATES CARDIAC SAFETY SERVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 186. UNITED KINGDOM CARDIAC SAFETY SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
TABLE 187. UNITED KINGDOM CARDIAC SAFETY SERVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 188. UNITED KINGDOM CARDIAC SAFETY SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 189. UNITED KINGDOM CARDIAC SAFETY SERVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 190. CARDIAC SAFETY SERVICES MARKET SHARE, BY KEY PLAYER, 2023
TABLE 191. CARDIAC SAFETY SERVICES MARKET, FPNV POSITIONING MATRIX, 2023

Companies Mentioned

  • ACM Global Laboratories
  • Advarra, Inc.
  • Banook Group
  • Biotrial
  • Celerion
  • Certara, Inc.
  • Charles River Laboratories International, Inc.
  • Circle Cardiovascular Imaging Inc.
  • Clario
  • Clyde Biosciences Limited
  • Eurofins Scientific SE
  • GE HealthCare Technologies Inc.
  • ICON PLC
  • IQVIA Holdings Inc.
  • Koninklijke Philips N.V.
  • Laboratory Corporation of America Holdings
  • Medpace, Inc.
  • MERIT CRO, Inc.
  • Metrion Biosciences Limited
  • Ncardia Services B.V.
  • NEXEL Co., Ltd.
  • Octagos Health, Inc.
  • Parexel International Corporation
  • PhysioStim SAS
  • PPD, Inc. by Thermo Fisher Scientific Inc.
  • Richmond Pharmacology Limited
  • Shanghai Medicilon Inc.
  • Worldwide Clinical Trials

Methodology

Loading
LOADING...

Table Information